Singapore-based Novo Tellus has invested an undisclosed sum in US-based Amsino Medical Group, a provider of medical consumable devices. The company will use the proceeds to expand its global footprint and operations.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
